INA-115E

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameINA-115E

Drug Alias Nameimmunotoxin (Inagen)INA-115E

ClassificationBiologics > Protein drugs > Immunoglobulin > AntibodyBiologics > Protein drugs > ToxinBiologics > Protein drugs > Recombinant protein > Fusion protein

Mechanisms of ActionCMV replication inhibitors

TargetsUpdating

Therapy Area/IndicationsCytomegalovirus Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryDenmark

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesInagen Aps

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesInagen Aps

Active IndicationsN/A

Inactive IndicationsCytomegalovirus Infections

Other Information

ATC CodeN/A